| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |